Metformin 500 mg Prolonged Release + Glimepiride 1 mg Bilayer Tablet
Effectively controls Diabetes & Obesity
| Packing | 10x15 Clear-PVC Blister |
| Dosage Form | Tablet |
| Category | Pharma |
| GST | 12% |
Glimedom M1
Glimedom M1 is a first choice combination of Glimepiride 1 mg + Metformin 500 mg (Prolonged release) to manage Hyperglycemia. This medicine achieves good glycemic control with better tolerability profile and improves the lipid profile. The combination can be used in Type-2 Diabetes and in Diabetes with or without Obesity.
USPs
- Made in world class WHO-GMP Certified Facility
- Excellent Packing.
- Bilayer tablet for better drug control and stability.
- Lower risk of hypoglycaemia & less weight gain than other sulfonylureas.
- Combination achieves good glycemic control with better tolerability profile.
- Reduces Blood Glucose more rapidly than Glipizide over first few weeks of treatment
- Safe in Patients with Cardiovascular Disease.
- Increased patient compliance due to small tablet size.
